| Literature DB >> 27294140 |
Pierce Nunley1, Faheem Sandhu2, Kelly Frank1, Marcus Stone1.
Abstract
Introduction. The lateral lumbar interbody fusion (LLIF) surgical approach has potential advantages over other approaches but is associated with some unique neurologic risks due to the proximity of the lumbosacral plexus. The present study analyzed complications following LLIF surgical approach using a novel single flat-blade retractor system. Methods. A retrospective data collection of patients receiving LLIF using a novel single flat-blade retractor system at two institutions in the US. Inclusion criteria were all patients receiving an LLIF procedure with the RAVINE® Lateral Access System (K2M, Inc., Leesburg, VA, USA). There was no restriction on preoperative diagnosis or number of levels treated. Approach-related neurologic complications were collected and analyzed postoperatively through a minimum of one year. Results. Analysis included 253 patients with one to four treated lateral levels. Immediate postoperative neurologic complications were present in 11.1% (28/253) of patients. At one-year follow-up the approach-related neurologic complications resolved in all except 5 patients (2.0%). Conclusion. We observed an 11.1% neurologic complication rate in LLIF procedures. There was resolution of symptoms for most patients by 12-month follow-up, with only 2% of patients with residual symptoms. This supports the hypothesis that the vast majority of approach-related neurologic symptoms are transient.Entities:
Mesh:
Year: 2016 PMID: 27294140 PMCID: PMC4880715 DOI: 10.1155/2016/8450712
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Intraoperative photograph of RAVINE.
Figure 2Intraoperative radiograph of RAVINE.
Figure 3Intraoperative radiograph of PEEK Cage Insertion using RAVINE.
Demographics.
| Sex | Male: 78, female: 175 |
| Age (years) | 61 (range 28–86) |
| Height (in) | 65.9 (range: 51–76) |
| Weight (lbs) | 181.4 (range: 107–301) |
| BMI (kg/m2) | 29.3 (range: 19.0–43.9), not noted: 9 |
| Current smoker | Yes: 47, no: 183, not noted: 23 |
Operative data.
| Lateral and posterior same-day ( | |
|---|---|
| LOS (days) | 2.36 (range: 1–10) |
| Surgery time (min) | 150.0 ± 56.2 (range: 58.0–360.0) |
| EBL (cc) | 87 (range: 10–700) |
|
| |
| Lateral and posterior staged ( | |
|
| |
| LOS (days) | 7.41 (range: 3–15) |
| Surgery time (min) | 453.2 ± 85.0 (range: 299.0–582.0) |
| EBL (cc) | 262 (range: 50–1350) |
|
| |
| Lateral stand-alone ( | |
|
| |
| LOS (days) | 3.88 (range: 1–13) |
| Surgery time (min) | 122.2 ± 38.9 (range: 77.0–216.0) |
| EBL (cc) | 55.2 (range: 15–300) |
Lateral and posterior levels treated.
| Lateral levels treated | Number of patients, lateral | Number of patients with neurological complication | |
|---|---|---|---|
| One | L1-L2 | 3 | 0 |
| L2-L3 | 19 | 0 | |
| L3-L4 | 52 | 0 | |
| L4-L5 | 85 | 2 | |
| L5-S1 | 1 | 0 | |
|
| |||
| Two | T12–L2 | 1 | 0 |
| L1–L3 | 4 | 0 | |
| L2–L4 | 17 | 0 | |
| L3–L5 | 34 | 1 | |
| L4–S1 | 3 | 0 | |
|
| |||
| Three | L1–L4 | 1 | 0 |
| L2–L5 | 25 | 2 | |
| L3–S1 | 1 | 0 | |
|
| |||
| Four | L1–L5 | 1 | 0 |
| L2–S1 | 6 | 0 | |
At final postoperative visit (average follow-up of 13.2 months).